期刊文献+

粪便钙卫蛋白检测在炎症性肠病中的应用价值 被引量:12

The application value of fecal calprotectin in inflammatory bowel disease
下载PDF
导出
摘要 炎症性肠病的诊断和监测主要依赖于临床表现、内镜和组织病理学及影像学检查。研究证实粪便炎症标志物可以作为内镜下诊断疾病活动性的一种替代指标。粪便钙卫蛋白是一种钙和锌结合的蛋白质,是肠道炎性细胞的直接产物,是临床上诊断和监测炎症性肠病的一种准确且非侵入性的生物标志物。文中旨在对粪便钙卫蛋白在炎症性肠病的诊断、活动性评价、临床监测及结局预测等方面的应用进展作一综述。 The diagnosis and monitoring of inflammatory bowel disease mainly depend on clinical presentation, endoscopical, histopathological and imaging findings. It has been demonstrated that fecal inflammatory biomarkers can be potential markers to replace endoscopy diagnosed disease activity. Calprotectin is a binding protein of calcium and zinc, which is mainly derived from neutrophi|s and macrophages. Calprotectin is an accurate noninvasive biomarker in diagnosing and monitoring inflammatory bowel disease in clin- ics. This paper reviews the progress of fecal calprotectin in the diagnosis, disease activity evaluation, clinical monitoring and prognosis of inflammatory bowel disease.
出处 《医学研究生学报》 CAS 北大核心 2015年第8期865-869,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(81270453)
关键词 粪便钙卫蛋白 炎症性肠病 诊断 预测 Fecal calprotectin Inflammatory bowel disease Diagnosis Prediction
  • 相关文献

参考文献7

二级参考文献94

共引文献615

同被引文献156

  • 1崔龙.提高外科手术在溃疡性结肠炎治疗中的作用[J].中华结直肠疾病电子杂志,2014,3(3):2-4. 被引量:6
  • 2刘文斌,吕愈敏,杨雪玲,金珠.粪便钙卫蛋白对溃疡性结肠炎活动性判断价值的研究[J].中华消化杂志,2005,25(7):394-397. 被引量:19
  • 3D'Haens G, Fen'ante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease[J], lnflamm Bowel Dis,2012,18(12) :2218-2224. 被引量:1
  • 4Ciecko-Michalska I, Fedak D, Maeh T. Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease[ J]. Przegl Lek ,2010,67 (12) : 1262-1265. 被引量:1
  • 5Husain N, Tokoro K, Popov J M, et al. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis [ J ]. J Clin Gastroenterol, 2013,47 ( 3 ) : 246 -251. 被引量:1
  • 6Naneey S, Bosehetti G, Moussata D, et al. Neopterin is a novel reliable fecal marker as accurate as ealproteetin for predicting en- doscopic disease activity in patients with inflammatory bowel dis- eases [ J ]. Inflamm Bowel Dis,2013.19 ( 5 ) : 1043-1052. 被引量:1
  • 7Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal clas- sification of inflammatory bowel disease: controversies, consen- sus, and implications[J]. Gut,2006,55(6) :749-753. 被引量:1
  • 8Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Dis- ease Study [ J ]. Gastroenterology, 1976,70 ( 3 ) :439 -444. 被引量:1
  • 9D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activi- ty indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [ J]. Gastroenterology, 2007,132(2) :763-786. 被引量:1
  • 10Campbell DI, Mcphail G, Lunn PG, et al. Intestinal inflamma-tion measured by fecal neopterin in Gambian children with enter- opathy: association with growth failure, Giardia lamblia, and in- testinal permeability [ J ]. J Pediatr Gastroenterol Nutr, 2004,39 (2) :153-157. 被引量:1

引证文献12

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部